Latest News about Cantor Fitzgerald
Recent news which mentions Cantor Fitzgerald
Legal Weed Stocks Dip Despite New Jersey Governor Signing Recreational Cannabis Bill Into Law
February 22, 2021
From Benzinga
4 Things Cannabis Investors Should Watch This Week
February 22, 2021
From Benzinga
Tilray Analysts On The Sidelines Despite Solid Earnings
February 18, 2021
From Benzinga
Why Cannabis MSOs Will 'Outperform S&P 500' In 2021
February 11, 2021
From Benzinga
Are You Following Analysts On These Penny Stocks?
January 15, 2021
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Coronavirus Spike Creates Risk For Cannabis MSOs
December 14, 2020
From Benzinga
From Benzinga
Pfizer-BioNTech Plan Vaccine Emergency Use Filing Within Days After Final Analysis Confirm Efficacy, Safety
November 18, 2020
From Benzinga
Green Thumb Industries Reports 131% Revenue Growth, Analyst Sees 'Significant Upside'
November 12, 2020
Tickers
GTBIF
From Benzinga
Why This Abeona Therapeutics Analyst Is Turning Bullish After Q3 Print
November 11, 2020
Tickers
ABEO
From Benzinga
Cantor Raises Canopy Growth Target After September Quarter Print
November 10, 2020
From Benzinga
Cannabis Stocks Rebound As Dust Settles Following US Election
November 05, 2020
From Benzinga
From Benzinga
A Pfizer Analyst's 3 Possible Coronavirus Vaccine Readout Scenarios
November 02, 2020
Tickers
PFE
From Benzinga
The Cannabis Markets In Latin America: A Snapshot By Expert Analysts
October 30, 2020
Tickers
PERU
From Benzinga
Why Cantor Fitzgerald Is No Longer An Aurora Cannabis Bull
October 27, 2020
From Benzinga
State-Owned Liquor Stores Are Key To Pennsylvania Recreational Cannabis Legalization
October 26, 2020
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Cannabis Stocks Soar On Heels Of VP Debate, Vermont Bill Passing
October 08, 2020
From Benzinga
The Cannabis Stocks Could Win If New Jersey Legalizes Adult Use
October 08, 2020
From Benzinga
Regeneron Requests Emergency Use Authorization, Analysts See Coronavirus Antibodies As Earnings Driver In 2021
October 08, 2020
From Benzinga
From Benzinga
Why Regeneron's Growth Opportunity Is Unappreciated
October 05, 2020
From Benzinga
Novavax Analysts Confident As Coronavirus Vaccine Candidate Heads To Phase 3 Study
September 25, 2020
Tickers
NVAX
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.